Friday, September 13, 2024

Eye on Qui Tam Settlements: C-Level Executive Awarded $6M

Header:  Former C-level executive gets $6M in False Claims Act qui tam case.

###

Note: This blog is based on a Policy & Medicine article online and links therein.  As stated there, the settlement is not an admission of liability and the entity denies the allegations.

See an article about a $34M false claims act settlement involving Da Vita:

https://www.policymed.com/2024/09/davita-reaches-34-million-false-claims-act-settlement.html

For more details of the allegations and settlement, see the link above.  See also (and similarly) a DOJ press release in July.

For a view into the court case, see online one of the underlying court documents:

https://www.justice.gov/opa/media/1360946/dl?inline

Policy & Medicine states:

  • The case was initially brought by the former Chief Operating Officer of DaVita Kidney Care under the qui tam provisions of the False Claims Act. 
  • For his role in the case, he will receive $6,370,000.